Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Pseudotumoral forms of multiple sclerosis: report of 14 cases and review of the literature.

Mauri-Fábrega L, Díaz-Sánchez M, Casado-Chocán JL, Uclés-Sánchez AJ.

Eur Neurol. 2014;72(1-2):72-8. doi: 10.1159/000358385. Epub 2014 Jun 4. Review.

PMID:
24903642
2.

Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis.

Hardmeier M, Wagenpfeil S, Freitag P, Fisher E, Rudick RA, Kooijmans-Coutinho M, Clanet M, Radue EW, Kappos L; European rIFN beta-1a in Relapsing MS Dose Comparison Trial Study Group.

Arch Neurol. 2003 Dec;60(12):1736-9.

PMID:
14676048
3.

Clinical and laboratory features of in-patients with multiple sclerosis in a University Hospital in Tokyo from 1988-2002.

Tanaka K, Kujuro Y, Suzuki S, Tanahashi N, Hamada J, Nogawa S, Suzuki N.

Intern Med. 2005 Jun;44(6):560-6.

4.

Atypical idiopathic inflammatory demyelinating lesions (IIDL): conventional and diffusion-weighted MR imaging (DWI) findings in 42 cases.

Koelblinger C, Fruehwald-Pallamar J, Kubin K, Wallner-Blazek M, van den Hauwe L, Macedo L, Puchner SB, Thurnher MM.

Eur J Radiol. 2013 Nov;82(11):1996-2004. doi: 10.1016/j.ejrad.2013.07.026. Epub 2013 Aug 12.

PMID:
23993757
5.

Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale.

Bakshi R, Neema M, Healy BC, Liptak Z, Betensky RA, Buckle GJ, Gauthier SA, Stankiewicz J, Meier D, Egorova S, Arora A, Guss ZD, Glanz B, Khoury SJ, Guttmann CR, Weiner HL.

Arch Neurol. 2008 Nov;65(11):1449-53. doi: 10.1001/archneur.65.11.1449.

6.

Corpus callosum index and long-term disability in multiple sclerosis patients.

Yaldizli O, Atefy R, Gass A, Sturm D, Glassl S, Tettenborn B, Putzki N.

J Neurol. 2010 Aug;257(8):1256-64. doi: 10.1007/s00415-010-5503-x. Epub 2010 Mar 3.

PMID:
20198382
7.

Enhancing patterns in multiple sclerosis: evolution and persistence.

He J, Grossman RI, Ge Y, Mannon LJ.

AJNR Am J Neuroradiol. 2001 Apr;22(4):664-9.

8.

[Relapsing-remitting inflammatory disease of the central nervous system with normal MRI: multiple sclerosis or phenocopy in a series of 15 patients].

Lebrun C, Bourg V, Chanalet S, Chatel M.

Rev Neurol (Paris). 2003 Apr;159(4):397-404. Review. French.

PMID:
12773868
9.

Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis.

Dalton CM, Bodini B, Samson RS, Battaglini M, Fisniku LK, Thompson AJ, Ciccarelli O, Miller DH, Chard DT.

Mult Scler. 2012 Mar;18(3):322-8. doi: 10.1177/1352458511420269. Epub 2011 Aug 30.

PMID:
21878451
10.

Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.

Pulizzi A, Rovaris M, Judica E, Sormani MP, Martinelli V, Comi G, Filippi M.

Arch Neurol. 2007 Aug;64(8):1163-8.

PMID:
17698707
11.

Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.

Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, Atzori M, Bernardi V, Barachino L, Rinaldi L, Perini P, Gallo P, Filippi M.

Arch Neurol. 2009 Sep;66(9):1144-50. doi: 10.1001/archneurol.2009.174.

PMID:
19752305
12.

Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.

van Walderveen MA, Lycklama A Nijeholt GJ, Adèr HJ, Jongen PJ, Polman CH, Castelijns JA, Barkhof F.

Arch Neurol. 2001 Jan;58(1):76-81.

PMID:
11176939
13.

MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis.

Zivadinov R, De Masi R, Nasuelli D, Bragadin LM, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M.

Neuroradiology. 2001 Apr;43(4):272-8.

PMID:
11338408
14.

TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis.

Papadopoulos K, Tozer DJ, Fisniku L, Altmann DR, Davies G, Rashid W, Thompson AJ, Miller DH, Chard DT.

Mult Scler. 2010 Apr;16(4):427-33. doi: 10.1177/1352458509359924. Epub 2010 Jan 19.

PMID:
20086026
15.

Natural history of multiple sclerosis: a unifying concept.

Confavreux C, Vukusic S.

Brain. 2006 Mar;129(Pt 3):606-16. Epub 2006 Jan 16.

PMID:
16415308
16.

Thalamic damage and long-term progression of disability in multiple sclerosis.

Rocca MA, Mesaros S, Pagani E, Sormani MP, Comi G, Filippi M.

Radiology. 2010 Nov;257(2):463-9. doi: 10.1148/radiol.10100326. Epub 2010 Aug 19.

PMID:
20724544
17.

Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients.

Le Page E, Leray E, Taurin G, Coustans M, Chaperon J, Morrissey SP, Edan G.

J Neurol Neurosurg Psychiatry. 2008 Jan;79(1):52-6. Epub 2007 Sep 10.

PMID:
17846110
18.

Clinical characteristics of patients with late-onset multiple sclerosis.

Kis B, Rumberg B, Berlit P.

J Neurol. 2008 May;255(5):697-702. doi: 10.1007/s00415-008-0778-x. Epub 2008 Feb 19.

PMID:
18283394
19.

Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.

Altintas A, Petek B, Isik N, Terzi M, Bolukbasi F, Tavsanli M, Saip S, Boz C, Aydin T, Arici-Duz O, Ozer F, Siva A.

Mult Scler. 2012 Oct;18(10):1448-53. Epub 2012 Mar 14.

PMID:
22419670
20.

Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study.

Calabrese M, Filippi M, Rovaris M, Bernardi V, Atzori M, Mattisi I, Favaretto A, Grossi P, Barachino L, Rinaldi L, Romualdi C, Perini P, Gallo P.

Mult Scler. 2009 Jan;15(1):36-41. doi: 10.1177/1352458508096686. Epub 2008 Aug 28.

PMID:
18755823

Supplemental Content

Support Center